The invention relates to the field of biochemistry, biophysical chemistry, molecular biology, structural biology and medicine. More in particular, the invention relates to cross-β structure conformation. Even more particular, the invention relates to compounds capable of binding to a compound with cross-β structure conformation, i.e. cross-β structure binding compounds and uses thereof.
Dominguez et al., Anales de la Real Sociedad Espanola de Fisica y Quimica, Serie B: Quimica, 1956, vol. 52, p. 43,45, 49
作者:Dominguez et al.
DOI:——
日期:——
CROSS-BETA STRUCTURE BINDING COMPOUNDS
申请人:Crossbeta Biosciences B.V.
公开号:EP1910844B1
公开(公告)日:2012-04-18
Konstitution und Synthese des Ammodendrins
作者:Clemens Sch�pf、Franz Braun
DOI:10.1007/bf00627183
日期:——
Ammodendrine and <i>N</i>-Methylammodendrine Enantiomers: Isolation, Optical Rotation, and Toxicity
作者:Stephen T. Lee、Russell J. Molyneux、Kip E. Panter、Cheng-Wei Tom Chang、Dale R. Gardner、James A. Pfister、Massoud Garrossian
DOI:10.1021/np0580199
日期:2005.5.1
ammodendrine fraction was reacted in a peptide coupling reaction with 9-fluorenylmethoxycarbonyl-L-alanine (Fmoc-L-Ala-OH) to give diastereomers, which were separated by preparative HPLC. The pure D- and L-ammodendrine enantiomers were then obtained by Edman degradation. Opticalrotation measurements revealed that the D- and L-enantiomers had opticalrotations of [alpha]24D +5.4 and -5.7, respectively